KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Total Current Liabilities (2016 - 2026)

NovoCure's Total Current Liabilities history spans 13 years, with the latest figure at $217.6 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 70.73% to $217.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $217.6 million, a 70.73% decrease, with the full-year FY2025 number at $223.2 million, down 70.49% from a year prior.
  • Total Current Liabilities hit $217.6 million in Q1 2026 for NovoCure, down from $223.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for NVCR hit a ceiling of $776.0 million in Q3 2025 and a floor of $127.8 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $337.0 million across 5 years, with a median of $169.2 million in 2024.
  • Biggest five-year swings in Total Current Liabilities: surged 367.67% in 2024 and later plummeted 70.73% in 2026.
  • Tracing NVCR's Total Current Liabilities over 5 years: stood at $158.8 million in 2022, then increased by 12.81% to $179.1 million in 2023, then surged by 322.3% to $756.4 million in 2024, then crashed by 70.49% to $223.2 million in 2025, then decreased by 2.53% to $217.6 million in 2026.
  • Business Quant data shows Total Current Liabilities for NVCR at $217.6 million in Q1 2026, $223.2 million in Q4 2025, and $776.0 million in Q3 2025.